Cargando…
Trapezoid bioequivalence: A rational bioavailability evaluation approach on account of the pharmaceutical‐driven balance of population average and variability
Among the current approaches for the analysis of bioequivalence, the average bioequivalence (ABE) is limited only to the mean bioavailability, whereas the population bioequivalence (PBE) criterion aggregates both mean and variance in a general comparison formula. However, a rational bioequivalence c...
Autores principales: | Soufsaf, Sara, Nekka, Fahima, Li, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007608/ https://www.ncbi.nlm.nih.gov/pubmed/35303757 http://dx.doi.org/10.1002/psp4.12775 |
Ejemplares similares
-
Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics
por: Bi, Goue Denis Gohore, et al.
Publicado: (2009) -
Alternative Analysis Approaches for the Assessment of Pilot Bioavailability/Bioequivalence Studies
por: Henriques, Sara Carolina, et al.
Publicado: (2023) -
Combined Methodologies for Determining In Vitro Bioavailability of Drugs and Prediction of In Vivo Bioequivalence From Pharmaceutical Oral Formulations
por: De Simone, A., et al.
Publicado: (2021) -
Predictive Potential of C(max) Bioequivalence in Pilot Bioavailability/Bioequivalence Studies, through the Alternative ƒ(2) Similarity Factor Method
por: Henriques, Sara Carolina, et al.
Publicado: (2023) -
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects
por: Tang, Fang, et al.
Publicado: (2016)